Galectin Therapeutics Inc (GALT)
3.34
-0.03
(-0.89%)
USD |
NASDAQ |
May 03, 16:00
3.36
+0.02
(+0.60%)
After-Hours: 20:00
Galectin Therapeutics Accounts Payable (Quarterly): 6.431M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.431M |
September 30, 2023 | 2.681M |
June 30, 2023 | 1.976M |
March 31, 2023 | 2.553M |
December 31, 2022 | 3.89M |
September 30, 2022 | 2.352M |
June 30, 2022 | 2.964M |
March 31, 2022 | 1.906M |
December 31, 2021 | 1.805M |
September 30, 2021 | 1.917M |
June 30, 2021 | 0.924M |
March 31, 2021 | 0.382M |
December 31, 2020 | 1.292M |
September 30, 2020 | 0.691M |
June 30, 2020 | 0.206M |
March 31, 2020 | 0.66M |
December 31, 2019 | 1.661M |
September 30, 2019 | 0.354M |
June 30, 2019 | 0.396M |
March 31, 2019 | 0.448M |
December 31, 2018 | 0.297M |
September 30, 2018 | 0.171M |
June 30, 2018 | 0.22M |
March 31, 2018 | 1.151M |
December 31, 2017 | 0.608M |
Date | Value |
---|---|
September 30, 2017 | 0.166M |
June 30, 2017 | 0.399M |
March 31, 2017 | 1.346M |
December 31, 2016 | 0.91M |
September 30, 2016 | 0.652M |
June 30, 2016 | 0.932M |
March 31, 2016 | 1.311M |
December 31, 2015 | 0.448M |
September 30, 2015 | 0.929M |
June 30, 2015 | 0.775M |
March 31, 2015 | 0.922M |
December 31, 2014 | 0.906M |
September 30, 2014 | 0.838M |
June 30, 2014 | 0.665M |
March 31, 2014 | 0.486M |
December 31, 2013 | 0.762M |
September 30, 2013 | 0.377M |
June 30, 2013 | 0.285M |
March 31, 2013 | 0.316M |
December 31, 2012 | 0.397M |
September 30, 2012 | 0.256M |
June 30, 2012 | 0.246M |
March 31, 2012 | 0.669M |
December 31, 2011 | 0.384M |
September 30, 2011 | 0.198M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.206M
Minimum
Jun 2020
6.431M
Maximum
Dec 2023
1.844M
Average
1.805M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 28.04M |
Viking Therapeutics Inc | 5.225M |
89bio Inc | 8.585M |
Terns Pharmaceuticals Inc | 2.515M |
Enanta Pharmaceuticals Inc | 9.326M |